(Q28272414)
Statements
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease (English)
Rodrigo Martino
M Estela Moreno
Anna Sureda
Salut Brunet
1 November 2006
scientific article